View cart You cannot add another "Symptoms Management in Cardiovascular Palliative Care Patients" to your cart.

Avoiding-the-unavoidable-SGLT2-inhibitor-in-secondary-prevention-of-CVD

Avoiding the unavoidable, SGLT2 inhibitor in secondary prevention of CVD

Rp25.000

Pembicara : dr. Ade Meidian Ambari, SpJP(K)

Category: Uncategorized

Reviews (0)

Reviews

There are no reviews yet.

Be the first to review “Avoiding the unavoidable, SGLT2 inhibitor in secondary prevention of CVD”